Abstract
A series of acetohydroxamic acid derivatives of 3-nitropyrazole were synthesized and evaluated for their ability to potentiate (chemosensitization) the activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) against EMT-6 mouse mammary tumor cells in vitro. The compounds were designed to test the hypothesis that the chemosensitizing activity of the analogues would be proportional to the rate of isocyanate formation via a Lossen rearrangement, in part a function of the leaving group at the N terminus of each acetohydroxamate. Substitution of acetohydroxamic acid side chains at the N-1 position of the parent 3-nitropyrazole resulted in compounds which were preferentially toxic to cells treated under hypoxic conditions, and which were capable of enhancing the toxicity of CCNU in hypoxia. As was observed for cytotoxicity, the enhancement of CCNU toxicity by these sensitizing agents was significantly reduced under aerobic treatment conditions. A strong correlation was established between hypoxic toxicity and chemosensitizing potency. The activity of the analogue, however, was not proportional to their excepted rates of Lossen rearrangement. Nevertheless, several potent chemosensitizing compounds were identified; some of which were 10–50 x 's more potent on a molar basis than Misonidazole, the reference chemosensitizing compound.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McNally NJ: Enhancement of chemotherapy agents. Int J Radiat Oncol Biol Phys 8:593–598, 1982
Siemann DW: Modification of chemotherapy by nitroimidazoles. Int J Radiat Oncol Biol Phys 10:1585–1594, 1984
Kennedy KA, Teicher BA, Rockwell S, Sartorelli AC: The hypoxic tumor cell: A target for selective cancer chemotherapy. Biochem Pharmacol 29:1–8, 1980
Teicher BA, Lazo JS, Sartorelli AC: Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41:73–81, 1981
Sutherland RM: Selective chemotherapy on noncycling cells in an in vitro tumor model. Cancer Res 34:3501–3503, 1974
Mulcahy RT: Chemical properties of nitrosoureas: Implications for interaction with Misonidazole. Int J Radiat Oncol Biol Phys 8:599–602, 1982
Mulcahy RT, Dembs NL, Ublacker GA: Enhancement of nitrosourea cytotoxicity by Misonidazole in vitro: Correlation with carbamoylating potential. Br J Cancer 49:307–313, 1984
Mulcahy RT: Carbamoylation, inhibition of glutathione reductase and chemopotentiation of nitrosoureas by Misonidazole. Int J Radiat Oncol Biol Phys 12:1393–1395, 1986
Wheeler GP: A review of studies on the mechanism of action of nitrosoureas. Am Chem Soc Symp Series 30:87–119, 1976
Fornace Jr AJ, Kohn KW, Kann Jr HE: Inhibition of the ligase step of excision repair by 2-chloroethyl isocyanate, a decomposition product of 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 38:1064–1069, 1978
Babson JR, Reed DJ: Inactivation of glutathione reductase by 2-chloroethyl nitrosourea-derived isocyanates. Biochem Biophys Res Commun 83:754–762, 1978
Kann HE, Schlott MA, Petkas A: Effects of structure and chemical activity on the ability of nitrosoureas to inhibit DNA repair. Cancer Res 40:50–55, 1980
Yale HL: The hydroxamic acids. Chem Rev 33:209–256, 1943
Bright RD, Hauser CR: The influence of substituents on the rates of decomposition of the potassium salts of dihydroxamic acids. The Lossen rearrangement. J Am Chem Soc 61:618–629, 1939
Mulcahy RT, Wustrow DJ, Kende AS: Preliminary evaluation of isocyanate-generating nitroheterocycles as chemosensitizers, radiosensitizers and hypoxic cell cytotoxic agents. Int J Radiat Oncol Biol Phys 10:1609–1613, 1984
Mulcahy RT, Wustrow DJ, Hark RR, Kende AS: Radiosensitization by acetohydroxamic acid derivatives of 3-nitropyrazole. Radiat Res 105:296–306, 1986
Jones RG, Mann MJ, McLaughlin KC: Substituted β aminoethylpyrazoles. J Org-Chem 19:1428–1433, 1954
Reimlinger H, Oth JFM: Editionen des Pyrazols an aktivierte Mehrfachbindungen, I. Chem Ber 97:331–338, 1964
Mulcahy RT: Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer +) and deficient (Mer-) cell lines. Cancer Res 46: 2892–2897, 1986
Siemann DW, Mulcahy RT: Sensitization of cancer chemotherapeutic agents by nitroheterocyclics. Biochem Pharm 35:111–115, 1986
Ahmad A, Socha J, Vecera M: Hydrolysis of benzohydroxamic acids. Collect Czechoslovak Chem Comm 39:3293–3303, 1974
Ashfaq A, Pytela O, Socha J, Vecera M: Hydrolysis of O-acetylbenzohydroxamic acid derivatives. Collect Czechoslovak Chem Comm 41:3308–3313, 1976
Workman P, Twentyman P: Enhancement by electronaffinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: Structure-relationships. Int J Radiat Oncol Biol Phys 8:623–626, 1982
Wasserman TH, Phillips TL, Johnson RJ, Gomer CJ, Lawrence GA, Sadee W, Marques RA, Levin VA, VanRaalte G: Initial United States clinical and pharmacologic evaluation of Misonidazole (Ro-07–0582), an hypoxic cell radiosenisitizer. Int J Radiat Oncol Biol Phys 5:775–786, 1979
Wiestier O, Kleihues P, Pegg AE: O6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors. Carcinogenesis 5:121–124, 1984
Myrnes B, Norstrand K, Giercksky KE, Sjunneskog C, Krokan H: A simplified assay for O6-methylguanine-DNA methyltransferase activity and its application to human neoplastic and non-neoplastic tissues. Carcinogenesis 5: 1061–1064, 1984
Mitchell EP, Schein PS: Contributions of nitrosoureas to cancer treatment. Cancer Treat Rep 70:31–41, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mulcahy, R.T., Wustrow, D.J., Hark, R.R. et al. Enhancement of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) toxicity by acetohydroxamic acid analogues of 3-nitropyrazole in vitro . Invest New Drugs 5, 281–287 (1987). https://doi.org/10.1007/BF00175299
Issue Date:
DOI: https://doi.org/10.1007/BF00175299